ResMed, Inc. (NYSE:RMD)
The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
bassettt
(66.76)
Submitted: 5/30/2011 9:36:29 PM :
Start Price:
$32.10
RMD Score:
-7.08
Great competitive position
Macro headwinds
Recs
tmeri
(68.46)
Submitted: 3/4/2011 9:22:34 PM :
Start Price:
$32.02
RMD Score:
-8.28
Because their strongest competitor, Respironics, has been bought by another company.
Recs
kmacstepic
(70.05)
Submitted: 2/28/2011 10:37:31 AM :
Start Price:
$31.66
RMD Score:
-7.06
ResMed manufactures sleep apnea equipment. Low debt, good sales + earnings growth, and a huge untapped market make ResMed a 'buy'. When they come out with home testing equipment I think many more people will be diagnosed with this condition and subsequently be treated for it.
Recs
sqrtk
(27.31)
Submitted: 10/7/2010 5:04:37 AM :
Start Price:
$33.33
RMD Score:
-26.13
Strong fundamentals, good price pattern
Recs
Press90
(27.60)
Submitted: 6/3/2010 9:43:32 AM :
Start Price:
$31.41
RMD Score:
-29.36
this company has a unique product, with little to no competition in it's industry, it possesses a book value of $175 per share, and is trading way below that value and it's intrinsic value. Not to mention the company has a great balance sheet and income statement. This is a golden chicken egg just waiting to hatch.
Recs
iiinsight
(34.60)
Submitted: 5/28/2010 12:45:43 PM :
Start Price:
$31.65
RMD Score:
-28.84
It is the most undervalued company in the market with strong growth, sound management and outstanding demand demographics. It is a pure play on the population being overweight and aging in US, Europe and Asia.
Recs
crazyhorse49
(< 20)
Submitted: 3/11/2009 6:27:21 PM :
Start Price:
$17.29
RMD Score:
-16.34
The CPAP machine I use is by Fisher & Paykel Healthcare but ResMed's equipment is ubiquitous in the diagnostic and treatment centers for sleep disorders. Growing market share and a 20% yoy share price increase makes it a dependable, if not spectacular performer.
Recs
kurzzz
(83.92)
Submitted: 10/23/2008 8:39:11 AM :
Start Price:
$17.40
RMD Score:
+18.24
At the bottom and going up
Recs
MajBAD0437
(< 20)
Submitted: 9/3/2008 11:46:41 AM :
Start Price:
$22.76
RMD Score:
+22.02
Agree w/2 of 8 StockScouter picks for 09/08.
Personally use their products every night.
Saved my marriage!
Recs
pipcelot
(< 20)
Submitted: 2/6/2008 11:33:37 PM :
Start Price:
$22.08
RMD Score:
+28.43
steady growth
Recs
KingPortu
(72.45)
Submitted: 1/25/2008 3:54:44 PM :
Start Price:
$22.69
RMD Score:
+25.74
rec'd it, then it ran on the resp acquisition. has come back now and long term i like it.
Recs
aussiepie28
(< 20)
Submitted: 10/4/2007 8:35:48 PM :
Start Price:
$20.12
RMD Score:
+56.96
No other devices come close to it
Recs
Steadtler
(< 20)
Submitted: 5/28/2007 12:06:23 PM :
Start Price:
$22.50
RMD Score:
+38.64
Down because of a recall, but this is still a very good business, seems well-managed. good time to buy.
Recs
cmbrewer58
(< 20)
Submitted: 4/25/2007 5:07:42 PM :
Start Price:
$21.30
RMD Score:
+44.55
Next Qtr will show everyone the growth is back
Recs
ll0o0ll
(99.09)
Submitted: 4/24/2007 10:32:56 AM :
Start Price:
$20.90
RMD Score:
+45.85
Buy on weakness.
Recs
Birder61
(< 20)
Submitted: 4/16/2007 8:46:43 PM :
Start Price:
$24.60
RMD Score:
+24.18
As a OSA sufferer, I use RMD products, and I appreciate their quality. There are many people yet to learn of their apnea, and the product market for them has tremendous upside. RMD has shown solid growth to date, and I see no reason things will chance in the near future.
Recs
edinberlin
(43.32)
Submitted: 3/15/2007 9:31:02 AM :
Start Price:
$23.31
RMD Score:
+24.94
A leader in treating sleep-related illness
Recs
Foolme2x
(91.60)
Submitted: 2/14/2007 8:29:00 PM :
Start Price:
$25.25
RMD Score:
+19.85
Consistent longterm outperformer.
Recs
nagloc68
(< 20)
Submitted: 2/7/2007 4:24:41 PM :
Start Price:
$25.07
RMD Score:
+20.09
Has always been managed very well, with a focus on Sales AND Profits. Has industry leading products with a new family of products to be released later 2007. More stable then competitor, and who could have spelled sleep apnea 5 years ago . . . now it is advertised on the radio drive-time shows.
Recs
RBIClub
(54.55)
Submitted: 2/3/2007 1:23:45 PM :
Start Price:
$27.58
RMD Score:
+9.24
A clear winner in it's field. Main competitor appears to be RESP. Financials are very strong and they were recently upgraded by an Analyst. They're due to report on 2/6/2007 and I'm hoping for some upside. Currently a Mid-Cap.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 34 : 1 2 Next »